Analystreport

Adverum Biotechnologies (NASDAQ:ADVM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.

Adverum Biotechnologies, Inc.  (ADVM) 
Last adverum biotechnologies, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: adverum.gcs-web.com/investor-overview